Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes

K. Brabnikova Maresova, K. Pavelka, JJ. Stepan,

. 2013 ; 92 (4) : 354-61.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK ProQuest Central from 2002-01-01 to 1 year ago
Medline Complete (EBSCOhost) from 2000-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest) from 2002-01-01 to 1 year ago
Health & Medicine (ProQuest) from 2002-01-01 to 1 year ago

The aim of this study was to investigate the acute effects of oral glucocorticoids in doses used in clinical practice on biochemical indices of the function of osteoclasts, osteoblasts, and osteocytes. In 17 adult patients suffering from various medical pathologies requiring systemic steroid therapy that were never before treated with glucocorticoids, glucocorticoid treatment was initiated (mean prednisolone equivalent dose of 23.1 ± 12.7 mg/day, range 10-50). Fasting morning serum concentrations of osteocalcin (OC), amino-terminal propeptide of type I procollagen (PINP), type 1 collagen cross-linked C-telopeptide (βCTX), soluble receptor activator of nuclear factor kappaB ligand (sRANKL), osteoprotegerin (OPG), sclerostin, Dickkopf-1 (Dkk-1), and high-sensitivity C-reactive protein (hsCRP) were measured at baseline and on three consecutive days. Significant reductions in serum OC, PINP, OPG, sclerostin, and hsCRP were observed during 96 h of glucocorticoid administration, while serum βCTX showed a significant percentual increase. A significant positive correlation was found between serum concentrations of Dkk-1 and βCTX after 96 h of treatment with glucocorticoids. A significant drop in serum sclerostin, OPG, and OC observed in this study may reflect the rapid glucocorticoid-induced apoptosis of osteocytes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13031765
003      
CZ-PrNML
005      
20131003104736.0
007      
ta
008      
131002s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00223-012-9684-4 $2 doi
035    __
$a (PubMed)23247536
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Brabnikova Maresova, Kristyna $u Institute of Rheumatology, Prague, Czech Republic.
245    10
$a Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes / $c K. Brabnikova Maresova, K. Pavelka, JJ. Stepan,
520    9_
$a The aim of this study was to investigate the acute effects of oral glucocorticoids in doses used in clinical practice on biochemical indices of the function of osteoclasts, osteoblasts, and osteocytes. In 17 adult patients suffering from various medical pathologies requiring systemic steroid therapy that were never before treated with glucocorticoids, glucocorticoid treatment was initiated (mean prednisolone equivalent dose of 23.1 ± 12.7 mg/day, range 10-50). Fasting morning serum concentrations of osteocalcin (OC), amino-terminal propeptide of type I procollagen (PINP), type 1 collagen cross-linked C-telopeptide (βCTX), soluble receptor activator of nuclear factor kappaB ligand (sRANKL), osteoprotegerin (OPG), sclerostin, Dickkopf-1 (Dkk-1), and high-sensitivity C-reactive protein (hsCRP) were measured at baseline and on three consecutive days. Significant reductions in serum OC, PINP, OPG, sclerostin, and hsCRP were observed during 96 h of glucocorticoid administration, while serum βCTX showed a significant percentual increase. A significant positive correlation was found between serum concentrations of Dkk-1 and βCTX after 96 h of treatment with glucocorticoids. A significant drop in serum sclerostin, OPG, and OC observed in this study may reflect the rapid glucocorticoid-induced apoptosis of osteocytes.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a kostní morfogenetické proteiny $x krev $7 D019485
650    _2
$a C-reaktivní protein $x metabolismus $7 D002097
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a kolagen typu I $x krev $7 D024042
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetické markery $7 D005819
650    _2
$a glukokortikoidy $x farmakologie $x terapeutické užití $7 D005938
650    _2
$a lidé $7 D006801
650    _2
$a mezibuněčné signální peptidy a proteiny $x krev $7 D036341
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a osteoblasty $x účinky léků $x metabolismus $7 D010006
650    _2
$a osteokalcin $x krev $7 D015675
650    _2
$a osteoklasty $x účinky léků $x metabolismus $7 D010010
650    _2
$a osteocyty $x účinky léků $x metabolismus $7 D010011
650    _2
$a osteoprotegerin $x krev $7 D053244
650    _2
$a peptidové fragmenty $x krev $7 D010446
650    _2
$a peptidy $x krev $7 D010455
650    _2
$a prokolagen $x krev $7 D011347
650    _2
$a prospektivní studie $7 D011446
650    _2
$a ligand RANK $x krev $7 D053245
650    _2
$a revmatické nemoci $x krev $x farmakoterapie $x patologie $7 D012216
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pavelka, Karel $u -
700    1_
$a Stepan, Jan J $u -
773    0_
$w MED00000994 $t Calcified tissue international $x 1432-0827 $g Roč. 92, č. 4 (2013), s. 354-61
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23247536 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20131002 $b ABA008
991    __
$a 20131003105254 $b ABA008
999    __
$a ok $b bmc $g 995852 $s 830210
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 92 $c 4 $d 354-61 $i 1432-0827 $m Calcified tissue international $n Calcif Tissue Int $x MED00000994
LZP    __
$a Pubmed-20131002

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...